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Background: Propolis is a resinous material extracted from bee glue with a complex chemical composition. The
unique biological properties of propolis have led to its use in alternative medicine and as a nutritional supplement. Recent research shows that propolis could aﬀect the immune system by decreasing the production of
inﬂammatory cytokines and potentiating an eﬀect on resident stem cells. The exact mechanism, however, is
unknown. The goal of this study was to demonstrate whether green propolis extract aﬀects any characteristic
properties of mesenchymal stromal cells (MSCs)in vitro.
Methods: The cytocompatibility of propolis extract and the proliferation of bone marrow mesenchymal stromal
cells (BMMSCs) in the presence of propolis was evaluated by live/dead cell staining and MTS viability assay over
a period of 3 days. Also, we evaluated the eﬀect of propolis extract on trilineage diﬀerentiation and migration
capacity of undiﬀerentiated and diﬀerentiated BMMSCs.
Results: Relative to the control, propolis extract resulted in a signiﬁcant and linear increase in the proliferation
of MSCs and inhibited the osteogenic diﬀerentiation of BMMSCs, while there was a potentiation of chondrogenesis and adipogenesis. Finally, in relevance to wound healing, an in vitro scratch assay demonstrated that
the migratory potential of diﬀerentiated BMMSCs was enhanced in the presence of propolis.
Conclusion: We have demonstrated that propolis extract was not toxic to BMMSCs (< 400 μg/ml), supported
their proliferation, potentiated chondrogenic and adipogenic diﬀerentiation processes, and supported cell migrationin vitro. Most interestingly, there was a down-regulation of osteogenesis. These data support the use of
propolis extract for enhanced cell proliferation and tissue regeneration; however, it warrants further investigation.

1. Introduction
Natural extracts represent a promising source of alternative medicine for many degenerative diseases. Their eﬀect is mediated by different factors, including their capacity to recruit stem cells, to increase
their proliferation, to migrate, and to enhance the diﬀerentiation of
endogenous stem cells [1–3]. Propolis is classiﬁed as a natural extract
from honeybee glue. It has been proven to have several positive biological eﬀects, such as being anti-inﬂammatory, anti-ulcerative, antibacterial, anti-oxidant, anti-tumor, and immunomodulatory, which favors its use in alternative medicine [4–13].
Propolis extracts exhibit complex chemical compositions and have
been reported to contain more than 300 organic and inorganic

compounds [14,15]. The major chemical components of Brazilian green
propolis extracts are prenylated phenylpropanoids, including caﬀeic
acids, cinnamic acids, P-coumoric acid, ferulic acid, and their derivatives. Caﬀeic acid phenethyl ester (CAPE) is one of the active components of propolis, which has been puriﬁed and tested in vitro and in vivo.
CAPE has been shown to be eﬀective for bone and cartilage regeneration [16–18], and some research has shown it to have an anticancer
eﬀect [19,20]. Studies have also demonstrated that ferulic acid has a
signiﬁcant eﬀect on nerve regeneration [21,22] and neovascularization
[23]. Cinnamic acid and its derivatives have been shown to protect
against diabetes [24]. Recently, 9 compounds in the brazilian green
propolis were found to possess free radical scavengers. Caﬀeoylquinic
acids and artepillin C exhibited strong antioxidant activity [25]. All of

Abbreviations: CAPE, caﬀeic acid phenethyl ester; BMMSC, bone marrow mesenchymal stromal cell; MSC, mesenchymal stromal cell; PLF, periodontal ligament
ﬁbroblasts; NO, nitric oxide; PBS, phosphate buﬀered saline; HBSS, Hank’s balanced salt solution HBSS; PI, propidium iodide; GAG, glycosaminoglycans
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coated ﬂasks in complete growth media composed of Dulbecco’s modiﬁed Eagle medium F-12 (DMEM F12), containing 10% fetal bovine
serum (Hyclone, Logan, UT, USA) and 1% penicillin/streptomycin solution in 37 °C in the presence of 5% CO2 (passage 0). Adherent cells
were harvested by 0.25% trypsin after they reached 80–90% conﬂuency. Cells were re-plated for further expansion or used in the in vitro
assays. BMMSCs between passages 3 to 6 were used in all the experiments described below. All experiments were carried out with 2 independent cell lines generated from each of the goats and each in vitro
assay was performed in triplicate. This resulted in 2 biological replicates and 3 technical replicates used in this study.

these components render propolis extracts with a unique bioactive effect. Due to the signiﬁcant variation in composition, the exact biological function of propolis in vivo is still under investigation.
In vitro, propolis extract has been evaluated for its cytotoxicity and
regenerative capacity using stem cells derived from dental pulp, exfoliated deciduous teeth [26–28], odontoblast, osteoclasts [29,30], and
ﬁbroblasts derived from skin and periodontal ligament [31–33]. Cytotoxicity of propolis has also been tested on macrophages [34–36]. In
another study, CAPE was shown to enhance the proliferative capacity of
umbilical cord blood-derived hematopoietic stem cells in vitro [37].
In addition, propolis has been found to have a protective eﬀect
against apoptosis, as it decreased the apoptosis of periodontal ligament
ﬁbroblasts (PLF) without any cytotoxicity. These data suggested that
propolis could serve as a beneﬁcial storage medium for an avulsed
tooth, as it could increase the viability and the physiological capability
of PLF [38].
At the site of injury, macrophages are responsible for the induction
of inﬂammation through the production of inﬂammatory cytokines and
nitric oxide (NO), and they participate in tissue regeneration through
the production of regulatory cytokines, such as IL10 [39,40]. Propolis
was shown to have an inhibitory eﬀect on inﬂammatory cytokines, such
as IL12, IL6, GM-CSF, IFN-Ɣ, IL-1β, TNF-α [41–43], and a stimulatory
eﬀect on the regulatory cytokines IL4, IL10, and TGF-β [42,43].
Moreover, it has an inhibitory eﬀect on the chemotaxis of CXCL2/MIP-2
and, hence, could potentially inhibit neutrophil migration [44].
In vivo, the oral administration of propolis enhanced the healing of
the fractured femur in a rat model, as evaluated by radiology, histology,
and bone mineral density [45]. These eﬀects were proposed to be due to
the antioxidant eﬀect of propolis. This was further conﬁrmed by measuring the plasma levels of endogenous antioxidants, superoxide dismutase, myeloperoxidase, and glutathione, which were found to be
signiﬁcantly decreased after propolis administration [45]. Another
study by Uçan et al. [46] reported that intraperitoneal injection of
CAPE, an active component of propolis, in a rat calvarial defect model
enhanced the eﬃciency of bone regeneration.
To our knowledge, there are no reports in the literature that describe the eﬀect of propolis extract on bone marrow-derived mesenchymal stromal cells (BMMSCs). Since bone marrow is one of the preferred sources of mesenchymal stromal cells (MSCs), in this study, we
investigated the eﬀect of propolis extract at diﬀerent concentrations
towards proliferation, cytotoxicity, and tri-lineage diﬀerentiation of
BMMSCs in vitro. In addition, we tested tissue regeneration potential of
propolis in vitro by measuring its eﬀect on the migration capacity of
undiﬀerentiated and diﬀerentiated MSCs (osteocyte, chondrocyte, and
adipocyte).

2.2. Preparation of the propolis extract solution
Green propolis extract was commercially obtained (Pharma Nectar,
Brazil). The extract used in this study was obtained from Baccharis
dracunculifolia, a Group 12 Brazilian propolis. Its chemical composition
is as described by the manufacturer (Lot# PC0214.1 V). Based on the
information from the manufacturer, green propolis extract did not
contain any preservatives or artiﬁcial ingredients.
The stock solution was prepared by dissolving 8 mg of green propolis extract into 40 ml Hank’s Balanced Salt Solution (HBSS) and
160 μl of ethyl alcohol. The solution was then kept in a 37 °C water bath
for 30 min to ensure the powder was completely dissolved. It was then
ﬁltered using a 0.2 μm syringe ﬁlter. This was the stock solution of
100% concentration.
Speciﬁc concentrations (10%, 20%, and 40%) of propolis were
prepared from the 100% stock solution in which the propolis stock was
diluted with the complete growth media. The amount of propolis in
each concentration of the working solutions was 200 μg, 400 μg, and
800 μg for 10%, 20%, and 40% concentrations, respectively. Complete
growth media without propolis was used as a control and is referred to
as containing 0% propolis solution.
2.3. Cell proliferation assay
BMMSCs were seeded in 24-well tissue culture polystyrene-coated
plates at a density of 5 × 103/well in the presence of the complete
growth media containing 0%, 10%, 20%, and 40% propolis. Cell proliferation was measured at 2 time points, days 1 and 3, using CellTitre
96® Aqueous nonradioactive (MTS) assay (Promega, Madison, WI) according to the manufacturer’s instructions. Brieﬂy, MTS reagent was
added to the cells and incubated for 3 h at 37 °C in 5% CO2. The absorbance of the formazan complex that formed was measured at
490 nm. Wells containing the same media without any cells were used
as blank controls.

2. Materials and methods
2.4. Live-dead cell staining
2.1. Bone marrow mesenchymal stromal cells
The viability of BMMSCs in the presence of the complete growth
media containing 0%, 10%, 20%, and 40% propolis was visualized
using calcein-am and propidium iodide (PI) staining (green and red
ﬂuorescence, respectively) (Invitrogen). Cells were stained according to
the manufacturer’s instructions after 2 days of seeding. This was carried
out to ensure all cells adhered to the polystyrene tissue culture plates
and were viable. Fluorescent images were acquired using Zeiss Axiovert
40C microscope, equipped with a Canon, Powershot A620 camera, and
images were evaluated with NIS-Elements™ imaging software (Nikon™).

The isolation and characterization of BMMSCs is as previously described [47,48]. Brieﬂy, heparinized bone marrow aspirate from goat
sternum was obtained according to the protocol approved by the Institutional Animal Care and Use Committee, University of Tennessee
(protocol no. 5027). The goats (n = 2) were sedated with detomidine
HCl (0.015–0.026 mg/kg bwt IV). The skin at the site of harvest was
desensitized by instilling 2% mepivacaine HCl subcutaneously. Ten
milliliters of bone marrow were collected from the region between the
4th-5th sternebra under ultrasound guidance and while administrating
heparin (300 IU/ml). Flunixin meglumine (1.1 mg/kg bwt IV) was injected to provide analgesia after the bone marrow aspiration. The aspirate was diluted 1:4 with phosphate buﬀered saline (PBS), layered
over Ficoll, and centrifuged for 20 min at 400 g. The cells containing the
mononuclear fraction at the interface of the PBS and Ficoll were aspirated and washed in PBS by centrifuging for 10 min at 200 g. The cell
pellet was then suspended and plated on tissue culture polystyrene

2.5. Nuclear-cytoplasm staining
Nuclear-cytoplasm ﬂuorescent staining was used to evaluate the
morphology of BMMSCs after culturing in the complete growth media
containing 0%, 10%, 20%, and 40% propolis for 7 days. For staining,
cells were ﬁxed with 4% paraformaldehyde for 10 min, and next, 5 μg of
wheat germ agglutinin (WGA, Alexa Fluor 488 conjugate) was added
2
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for 10 min at room temperature. After washing, cells were stained with
5 μg of TO-PRO-3 iodide stain (Alexa Fluor 647 conjugate) for 10 min at
room temperature. Finally, cells were mounted with SlowFade Gold
Antifade Reagent, and images were taken with a confocal microscope
(Leica TCS SP2; Leica Microsystems©, Wetzlar, Germany) at 20X
magniﬁcation.
2.6. Tri-lineage diﬀerentiation assays
Osteogenic, chondrogenic, and adipogenic diﬀerentiations were
performed as previously described with slight modiﬁcations [47,49].
Brieﬂy, 2 × 105 cells were seeded in the complete growth media containing 0%, 10%, 20%, and 40% propolis. Forty-eight hours later, when
the cells reached 70% conﬂuency, lineage-speciﬁc diﬀerentiation was
induced. Cells were fed with the lineage-speciﬁc diﬀerentiation media,
and the concentration of propolis extract was maintained throughout
the diﬀerentiation process. For each diﬀerentiation assay, an identical
number of cells without any diﬀerentiation media were used as controls.
Tri-lineage diﬀerentiation was visualized by phase contrast microscopy and cell-speciﬁc staining. The following staining techniques were
used: Alizarin red staining at day 21, Alcian blue staining at day 14, and
Oil-red-O staining at day 7, for osteogenesis, chondrogenesis, and adipogenesis, respectively. All images were obtained using a Zeiss Axiovert
40C microscope equipped with a Canon, Powershot A620 camera.

Fig. 1. Proliferation of BMMSCs. MTS assay was used to demonstrate the proliferation of BMMSCs cultured in complete growth media containing 0%, 10%,
20%, and 40% propolis over a period of 3 days. *P < 0.05 is considered signiﬁcant. The dotted line represents the control value and bars above or below
demonstrate changes relative to the control.

curve, wherein the proliferation of goat BMMSCs was measured in the
presence of 8, 50, 80, and 800 mgs of propolis. Cells exposed to complete growth media without any propolis (referred to as 0%) were used
as controls. Results showed that all the propolis concentrations, except
the 8 mg dose, resulted in a signiﬁcant decrease in cell proliferation
(data not shown). As the 8 mg concentration resulted in a signiﬁcantly
higher proliferation rate in comparison to the 50, 80, and 800 mgs
concentrations, we decided to use 10, 20, 40, 50, and 60% dilutions
from the 8 mg stock.
There was a signiﬁcant increase in cell proliferation in the presence
of 10% propolis only (0.19 ± 0.009) compared to the control
(0.155 ± 0.005) over a period of 3 days (p < 0.05) (Fig. 1). The 20%
and 40% propolis resulted in a signiﬁcantly higher proliferation rate at
day 1 only (0.151 ± 0.002 and 0.147 ± 0.001, respectively) relative
to the control (0.12 ± 0.002) (p < 0.05). After 3 days, 20% propolis
did not show any signiﬁcant diﬀerence, whereas 40% propolis demonstrated a signiﬁcantly lower proliferation (0.133 ± 0.002). This
was further conﬁrmed by the live/dead ﬂuorescent staining of cells
(Fig. 2). The presence of green ﬂuorescent (calcein-am) and very few
red ﬂuorescent (PI) BMMSCs after 48 h of seeding in the complete
growth media containing 10% and 20% propolis indicated that
BMMSCs were viable and that the 10% and 20% propolis solutions were
not cytotoxic. However, higher concentrations, such as 40% propolis,
were cytotoxic to cells after 2 days of culture, conﬁrming the proliferation assay data at day 3.
Cell morphology was visualized using TO-PRO-3 stain, a probe for
nucleic acid detection, along with WGA speciﬁc to the cell membrane,
to demonstrate the nucleus and the cytoplasmic structure of BMMSCs
cultured in complete growth media containing 10%, 20%, and 40%
propolis. Similar to the controls, cells showed an intact nucleus and
healthy cytoplasm using ﬂuorescence microscopy. No diﬀerences were
observed between the four groups, except lower numbers of cells were
observed in 40% propolis (Fig. 3), conﬁrming the reduced proliferation
and cytotoxicity.

2.7. Migration assay
Migration of undiﬀerentiated BMMSCs in the presence of the complete growth media containing 0%, 10%, and 20% propolis was demonstrated in vitro using a scratch assay. BMMSCs were seeded at a
density of 20.000 cells/cm2 to form a monolayer. Migration of diﬀerentiated BMMSCs (osteogenic, chondrogenic, and adipogenic diﬀerentiated cells) in the presence of the lineage-speciﬁc diﬀerentiation
media containing 0%, 10%, and 20% propolis was also assessed.
BMMSCs were induced to diﬀerentiate using the speciﬁc diﬀerentiating
media for each type as mentioned above.
In all the undiﬀerentiated and diﬀerentiated samples, one scratch/
sample/well was made with a 200 μl pipette tip to ensure that a gap of
400–500 μM was created in each well. Cellular debris was gently washed with HBSS.
Each scratch assay was repeated in triplicate in two independent
experiments. For gap closure, two randomly selected points along each
“wound” were identiﬁed, and the horizontal distance between the two
scratched edges was measured using black and white phase-contrast
microscopy. Measurements were made at day 1, 2, 3, 4, 6, 8, and 10
post-wounding. Measurements taken at each time-point were compared
to measurements at time 0 and then expressed as a percentage healing
relative to the original size of the gap.
2.8. Statistical analysis
All data are reported as mean ± SD. The data was ﬁrst evaluated
for normality using a Shapiro Wilk test, and after it was conﬁrmed to be
normally distributed, data was compared using a one-way-ANOVA with
Tukey's t-test for post hoc analysis. In all cases, a p-value of p < 0.05
was considered statistically signiﬁcant.

3.2. Propolis enhances chondrogenic and adipogenic diﬀerentiation, but not
osteogenic diﬀerentiation

3. Results
To determine the multipotency of the BMMSCs in the presence of
propolis in vitro, cells were induced to diﬀerentiate to osteogenic,
chondrogenic, and adipogenic lineages in the presence of 10%, 20%,
and 40% propolis. In this assay, lineage-speciﬁc media without propolis
was used as the 0% diﬀerentiation media control for each cell type.
Subjective evaluation by Alizarin red staining showed that BMMSCs
treated with all three concentrations of propolis did not show any

3.1. Propolis enhances cell proliferation and viability
Cell proliferation rate of previously isolated, characterized, and
cryopreserved goat BMMSCs [47] was evaluated in the presence of
green propolis extract in vitro.
Propolis concentrations used in this study were based on a dose
3
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Fig. 2. Cell viability of BMMSCs. Fluorescent staining was carried out 48 h after seeding BMMSCs in complete growth media containing 0%, 10%, 20%, and 40%
propolis. Cells were stained with Calcein-am, which emits green ﬂuorescence in live cells. Lack/reduced red ﬂuorescently stained cells by PI indicates dead cells.
Scale bar = 100 μm; images were taken at 10x magniﬁcation.

mineralized nodules compared to the control (Fig. 4A), suggesting that
cells failed to undergo osteogenic diﬀerentiation in the presence of
propolis. However, as judged by Alcian blue staining, BMMSCs demonstrated the potential to undergo chondrogenesis in vitro when
grown in the lineage-speciﬁc medium in the presence of 10% and 20%
(Fig. 4B). Similarly, as conﬁrmed by Oil red O staining (Fig. 4C), 10%
propolis treated cells showed a higher formation of fat droplets compared to the control. On the contrary, 20% and 40% propolis showed
relatively less accumulation of fat droplets relative to the control.

relative to the control (Fig. 7B). Similarly, signiﬁcant eﬀects in gap
closure were consistently observed at days 1, 2, 3, and 4 in adipogenic
cells with 20% propolis (Fig. 8A). At days 6, 8, and 10, both 10% and
20% propolis-treated adipocytes exhibited signiﬁcantly higher migration capacity relative to the control (p < 0.05). Staining the adipocyteinduced cells using Oil red-O revealed signiﬁcantly higher fat droplets
in the presence of 20% propolis relative to the control (Fig. 8B).

3.3. Propolis enhances migration of BMMSCs and promotes gap closure in
vitro

Green propolis extract used in this study was commercially obtained
(Pharma Nectar, Brazil), and active components reported were
Coumaric acid, Pinobankisin, pnocembrin, Pinobanksin-3-acetate,
chrysin, Galahgin, Artepillin C, and Baccharin. Propolis belongs to
group 12 of Brazilian propolis, and its botanical origin is identiﬁed as
Baccharis dracunculifolia.
Many studies have tested the eﬀect of propolis on not only grafts
and tissues, but also on diﬀerent cell lines in vitro; however, there are no
reports on its eﬀect on bone marrow-derived MSCs. Herein, we used in
vitro experiments to evaluate the cytotoxic eﬀect of propolis quantitatively and qualitatively. Our results revealed that propolis was not cytotoxic at concentrations lower than 400 μg/ml to BMMSCs, and in fact,
it increased the proliferation rate of BMMSCs. This ﬁnding was in
agreement with previously published studies, which reported that
propolis could enhance the proliferation capacity of periodontal ligament ﬁbroblast [38] and stem cells derived from exfoliated deciduous
teeth [28]. However, an opposite eﬀect was reported by Tyszka-Czochara et al., who observed that propolis exhibited an anti-proliferative
eﬀect on skin ﬁbroblast [32].
Propolis is one of the natural extracts used for osteoarthritis due to
its anti-inﬂammatory eﬀect, which has been shown in an in vivo arthritis-induced animal model [50–53]. In the present study, as conﬁrmed by Alcian blue staining for the glycosaminoglycans (GAG),
propolis showed aggregated GAG at 10% and 20% concentrations. This
eﬀect was also observed at 50% concentration (data not shown). It has
recently been shown that propolis extract could increase the extracellular matrix GAG and hyaluronic acid in a minor skin burn [54]. In

4. Discussion

An in vitro scratch assay was performed to mimic the in vivo eﬀect of
propolis on wound healing. Using this test, the undiﬀerentiated BMMSC
migration and wound gap closure was assessed in the presence of
complete growth media containing 0%, 10%, and 20% propolis over a
period of 10 days. Almost 85% of gap closure was observed at day 4 in
all groups tested. Data was not signiﬁcant at any time point (Fig. 5).
Since the 40% propolis solution demonstrated a lower proliferation rate
and some cell death (Figs. 1,2), it was not used in the migration assay.
The migration capacity of BMMSCs induced for osteogenic, chodrogenic, and adipogenic lineages was also assessed in the presence of
diﬀerentiation media containing 0%, 10%, and 20% propolis. The gap
closure of cells after osteogenic diﬀerentiation in presence of propolis
was signiﬁcantly shorter than the control until day 6 for 20% but relapsed after day 8 and became signiﬁcantly longer than the control
thereafter (Fig. 6A). Alizarin red staining of the cells after migration
showed poor osteogenic diﬀerentiation in both 10% and 20% propolistreated cells compared to the control (Fig. 6B), again conﬁrming the
earlier data that propolis extract inhibits osteogenesis (Fig. 4). On the
other hand, 10% propolis upregulated chondrogenic lineage diﬀerentiation at 24 h, and this eﬀect sustained until the end of the experiment at day 10. Both 10% and 20% propolis-treated cells showed signiﬁcantly higher migration capacity at days 3, 6, and 10 (Fig. 7A).
Alcian blue staining of the cells revealed an eﬃcient migration of
chondrocytes to close the gap in the presence of 10% and 20% propolis

Fig. 3. Nuclear-cytoplasmic morphology of BMMSCs. Representative confocal images of cytoplasmic (WGA, green) and nuclear (TOPRO-3-iodide, red) ﬂuorescent
stains show the integrity of BMMSCs cultured in complete growth media containing 0%, 10%, 20%, and 40% propolis. Cells were stained after 7 days of seeding and
proliferation. Scale bar = 25 μm.
4
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Fig. 4. Tri-lineage diﬀerentiation i.e. osteogenic, chondrogenic, and adipogenic diﬀerentiation of BMMSCs. Representative images show Alizarin red (A), Alcian blue
(B), and Oil red O (C) staining of osteocytes, chondrocytes, and adipocytes, respectively, after in vitro diﬀerentiation in lineage-speciﬁc diﬀerentiation media
containing 0%, 10%, 20%, and 40% propolis.

in the antioxidant levels at the site of the fracture as investigated by
Guney et al. [45]. Our data suggest the bone regenerative eﬀect of oral
propolis may not be via induction of osteodiﬀerentiation of MSCs as
believed by some researchers. Future experiments to understand the
lack of osteogenic diﬀerentiation observed in our study need to be initiated.
Some studies suggest that the injection of diﬀerentiated cells will
promote tissue regeneration [58–61]. As per our knowledge, there are
no reports about the capacity of diﬀerentiated cells to migrate to the
site of injury. Herein, we evaluated the eﬀect of propolis on the in vitro
migration potential of both undiﬀerentiated and diﬀerentiated MSCs
using scratch assay. Data shows that 10% and 20% propolis can potentiate the migration capacity of both chondro- and adipo-diﬀerentiated MSCs. The eﬀect of propolis on migration potential of diﬀerentiated cells observed in this study is novel and has not been reported
earlier. Previously, a single report by Jacob et al. [33] shows that

another study, propolis has been reported to increase collagen production in an animal model of diabetic wound healing via TGF-β1/
Smad2 signaling [55]. The published studies and data reported in this
study suggest that the dose of propolis used is important, and propolis
extract at a deﬁned concentration can be used as a suitable medium for
the storage and transportation of osteochondral graft and as a multifunctional carrier for stem cell therapy in osteoarthritis patients.
We observed that BMMSCs showed poor osteogenic diﬀerentiation
in the presence of propolis, suggesting that propolis extract may exert
an inhibitory eﬀect on osteogenic diﬀerentiation. This result is supported by Hidaka et al. [56] in which they demonstrated that propolis
exerted an inhibitory eﬀect on amorphous calcium phosphate formation. However, studies by Guney et al. [45] and Altan et al. [57] proposed a potential role for propolis in bone regeneration. It seems that
this in vivo eﬀect could be due to either its inhibitory eﬀect on the osteoclast maturation as explained by Pileggi et al. [30] or due to change

Fig. 5. Migration assay of undiﬀerentiated (non-diﬀerentiated)
BMMSCs. Quantitative analysis of the migration distance of
BMMSCs cultured in complete growth media containing 0%, 10%,
and 20% propolis. Results are shown as the mean ± SD of triplicates within two independent experiments. None of the data is
signiﬁcant.

5
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Fig. 6. Migration assay during osteogenic differentiation of BMMSCs. (A) Quantitative analysis to compare the migration of BMMSCs
cultured in osteogenic diﬀerentiation media
containing 0%, 10%, and 20% propolis. Results
are shown as the mean ± SD of triplicates
within
two
independent
experiments.
*P < 0.05 is considered signiﬁcant. (B)
Representative images showing the corresponding Alizarin red staining for osteogenic
diﬀerentiation.

1000 μg/ml propolis has an enhancing eﬀect on skin ﬁbroblast migration in vitro.
In terms of clinical applications, future studies would determine
whether propolis increases the viability and physiological health of
osteochondral graft and can act as a storage media, as it did for the
avulsed tooth. In addition, a cartilage defect animal model can be used
to determine the eﬀect of propolis as a carrier for MSCs to enhance
cartilage regeneration.

concentration is safe, cytocompatible, and, hence, can be used as an
adjuvant therapeutic supplement which has the potential to enhance
the proliferation and the tissue regeneration potential of MSCs. Due to
the high degree of variability in the chemical composition of propolis
extracts obtained from diﬀerent geographical locations, these in vitro
analyses should be performed prior to in vivo application. Most importantly, the in vitro system reported in this study provides an avenue
to understand the mechanisms of osteogenic, chondrogenic, and adipogenic diﬀerentiation processes of MSCs in the presence of a deﬁned
dose and type of propolis extract.

5. Conclusions
Competing interests

Within the scope of this study, we have demonstrated that propolis
at concentrations of ≤ 400 μg/ml was not cytotoxic to BMMSCs and
enhanced their proliferation. The higher concentrations, however,
hindered the proliferation and exhibited a cytotoxic eﬀect. Most importantly, we demonstrated that propolis enhanced the chondrogenic
and adipogenic diﬀerentiation processes and increased the migration
potential of diﬀerentiated cells from both lineages. In line with the
previous reports, our data supports the fact that propolis at a deﬁned
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Fig. 7. Migration assay during chondrogenic
diﬀerentiation of BMMSCs. (A) Quantitative
analysis to compare the migration of BMMSCs
cultured in chondrogenic diﬀerentiation media
containing 0%, 10%, and 20% propolis. Results
are shown as the mean ± SD of triplicates
within
two
independent
experiments.
*P < 0.05 is considered signiﬁcant. (B)
Representative images showing the corresponding Alcian Blue staining for chondrogenic
diﬀerentiation.
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Fig. 8. Migration assay during adipogenic differentiation. (A) Quantitative analysis to compare the migration of BMMSCs cultured in
adipogenic diﬀerentiation media containing
0%, 10%, and 20% propolis. Results are shown
as the mean ± SD of triplicates within two
independent experiments. *P < 0.05 is considered signiﬁcant. (B) Representative images
showing the corresponding Oil-red-O staining
for adipogenic diﬀerentiation.
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